FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)

View source ↗

Summary

FDA approves a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

SUPPL AP for PEGASYS (PEGINTERFERON ALFA-2A)